Genetic polymorphisms affect therapeutic response to angiotensin-converting enzyme inhibitors in Chinese hypertensive patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-OCH-12002611

Enrollment

Unknown

Registered

2012-09-15

Start date

2007-06-06

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

control group:no

hypertension group:antihypertensive drug

Eligibility

Sex/Gender

All

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients diagnosed with primary hypertension,having mean systolic blood pressure >=140 mmHg and =90mmHg and <110 mmHg without antihypertensive therapy.

Exclusion criteria

Exclusion criteria: Secondary hypertension; pregnant or lactating were excluded from this study

Design outcomes

Primary

Measure	Time frame
related gene;Blood pressure;	—

Countries

China

Contacts

Public ContactWei Zhang

yjsd2003@163.com+86 0731 84805380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026